Model-based approach for human kinematics reconstruction from markerless and marker-based motion analysis systems.

J Biomech

Laboratory of Anatomy, Biomechanics and Organogenesis (LABO), Faculty of Medicine Université Libre de Bruxelles (ULB), Belgium; Department of Applied Mathematics, Polytechnical University, Saint Petersburg, Russia. Electronic address:

Published: September 2013

Modeling tools related to the musculoskeletal system have been previously developed. However, the integration of the real underlying functional joint behavior is lacking and therefore available kinematic models do not reasonably replicate individual human motion. In order to improve our understanding of the relationships between muscle behavior, i.e. excursion and motion data, modeling tools must guarantee that the model of joint kinematics is correctly validated to ensure meaningful muscle behavior interpretation. This paper presents a model-based method that allows fusing accurate joint kinematic information with motion analysis data collected using either marker-based stereophotogrammetry (MBS) (i.e. bone displacement collected from reflective markers fixed on the subject's skin) or markerless single-camera (MLS) hardware. This paper describes a model-based approach (MBA) for human motion data reconstruction by a scalable registration method for combining joint physiological kinematics with limb segment poses. The presented results and kinematics analysis show that model-based MBS and MLS methods lead to physiologically-acceptable human kinematics. The proposed method is therefore available for further exploitation of the underlying model that can then be used for further modeling, the quality of which will depend on the underlying kinematic model.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbiomech.2013.07.037DOI Listing

Publication Analysis

Top Keywords

model-based approach
8
human kinematics
8
motion analysis
8
modeling tools
8
human motion
8
muscle behavior
8
motion data
8
kinematics
5
motion
5
model-based
4

Similar Publications

A vision model for automated frozen tuna processing.

Sci Rep

January 2025

School of Food and Pharmacy, Zhejiang Ocean University, Zhoushan, 316022, People's Republic of China.

Accurate and rapid segmentation of key parts of frozen tuna, along with precise pose estimation, is crucial for automated processing. However, challenges such as size differences and indistinct features of tuna parts, as well as the complexity of determining fish poses in multi-fish scenarios, hinder this process. To address these issues, this paper introduces TunaVision, a vision model based on YOLOv8 designed for automated tuna processing.

View Article and Find Full Text PDF

Development of an in vivo ovarian cancer peritoneal carcinomatosis model for radioimmunotherapy testing.

Methods Cell Biol

January 2025

Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier (ICM), Montpellier, France. Electronic address:

Currently, Ovarian Cancer (OC) is the most lethal gynecological malignancy. In most patients, it progresses without clinical signs or symptoms, leading to a late diagnosis when it has already spread in the peritoneal cavity as peritoneal carcinomatosis (PC). To date, OC PC management is based on cytoreductive surgery to remove the macroscopic disease, followed by chemotherapy.

View Article and Find Full Text PDF

Two algorithms for improving model-based diagnosis using multiple observations and deep learning.

Neural Netw

January 2025

College of Computer Science and Technology, Jilin University, Changchun, 130012, China; Key Laboratory of Symbolic Computation and Knowledge Engineering, Ministry of Education, Jilin University, Changchun, 130012, China. Electronic address:

Model-based diagnosis (MBD) is a critical problem in artificial intelligence. Recent advancements have made it possible to address this challenge using methods like deep learning. However, current approaches that use deep learning for MBD often struggle with accuracy and computation time due to the limited diagnostic information provided by a single observation.

View Article and Find Full Text PDF

Population pharmacokinetics of erlotinib in patients with non-small cell lung cancer (NSCLC): A model-based meta-analysis.

Comput Biol Med

January 2025

Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, Republic of Korea; Department of Pharmaceutical Medicine and Regulatory Science, Yonsei University, Incheon, Republic of Korea; Graduate Program of Industrial Pharmaceutical Science, Yonsei University, Incheon, Republic of Korea; Department of Integrative Biotechnology, Yonsei University, Incheon, Republic of Korea. Electronic address:

Background: Erlotinib is a potent first-generation epidermal growth factor receptor tyrosine kinase inhibitor. Due to its proximity to the upper limit of tolerability, dose adjustments are often necessary to manage potential adverse reactions resulting from its pharmacokinetic (PK) variability.

Methods: Population PK studies of erlotinib were identified using PubMed databases.

View Article and Find Full Text PDF

Objectives: To develop a nomogram based on the radiomics features of tumour and perigastric adipose tissue adjacent to the tumor in dual-layer spectral detector computed tomography (DLCT) for lymph node metastasis (LNM) prediction in gastric cancer (GC).

Methods: A retrospective analysis was conducted on 175 patients with gastric adenocarcinoma. They were divided into training cohort (n = 125) and validation cohort (n = 50).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!